World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
40187
World Ranking
11579
National Ranking
5942

Overview

David G. Pfister is affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research primarily focuses on medical fields with extensive work in oncology, surgery, pulmonary and respiratory medicine, otorhinolaryngology, and radiology, nuclear medicine, and imaging.

The main areas of study cover:

  • Medicine

Within these broad fields, the scientist's subfields of study include:

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Oncology
  • Otorhinolaryngology
  • Radiology, Nuclear Medicine and Imaging

The research topics addressed involve:

  • Head and Neck Cancer Studies
  • Head and Neck Surgical Oncology
  • Salivary Gland Tumors Diagnosis and Treatment
  • Cancer Diagnosis and Treatment
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Diagnosis and Treatment
  • Prostate Cancer Diagnosis and Treatment

David G. Pfister has contributed to several recent papers, notably:

  • Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology (2020), published in Journal of the National Comprehensive Cancer Network
  • Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial (2021), published in The Lancet Oncology
  • NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022 (2022), published in Journal of the National Comprehensive Cancer Network
  • Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma (2020), published in Journal of Clinical Oncology
  • Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial (2020), published in JNCI Journal of the National Cancer Institute

Their frequent co-authors include:

  • Eric J. Sherman
  • Alan L. Ho
  • Lara Dunn
  • Richard J. Wong
  • Loren S. Michel

David G. Pfister's work has been published regularly in these venues:

  • Journal of Clinical Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • The Journal of Urology
  • Journal of the National Comprehensive Cancer Network
  • Oral Oncology

Best Publications

  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types.

    Robert M Samstein;Chung-Han Lee;Chung-Han Lee;Alexander N Shoushtari;Alexander N Shoushtari;Matthew D Hellmann;Matthew D Hellmann

  • American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003

    David G. Pfister;David H. Johnson;Christopher G. Azzoli;William Sause

  • Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin

    Jose Baselga;D. Pfister;M. R. Cooper;R. Cohen

  • Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*

    Abram Recht;Stephen B. Edge;Lawrence J. Solin;David S. Robinson

  • [American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer].

    Christopher G. Azzoli;Sherman Baker;Sarah Temin;William Pao

  • Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.

    David G. Pfister;Sharon Spencer;David Adelstein;Douglas Adkins

  • Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines

    Richard J. Gralla;David Osoba;Mark G. Kris;Peter Kirkbride

  • Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer

    Alan L. Ho;Ravinder K. Grewal;Rebecca Leboeuf;Eric J. Sherman

  • Colorectal Cancer Surveillance: 2005 Update of an American Society of Clinical Oncology Practice Guideline

    Christopher E. Desch;Al B. Benson;Mark R. Somerfield;Patrick J. Flynn

  • Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study.

    Joshua Bauml;Tanguy Y. Seiwert;David G. Pfister;Francis Worden

  • Head and Neck Cancers, Version 2.2014

    David G. Pfister;Sharon Spencer;David M. Brizel;Barbara Burtness

  • American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer

    David G. Pfister;Scott A. Laurie;Gregory S. Weinstein;William M. Mendenhall

  • Activity of XL184 (cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer

    Razelle Kurzrock;Steven I. Sherman;Douglas W. Ball;Arlene A. Forastiere

  • Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer

    Samuel A. Wells;Jessica E. Gosnell;Robert F. Gagel;Jeffrey Moley

  • Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience

    Suzanne L. Wolden;William C. Chen;David G. Pfister;Dennis H. Kraus

  • NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018

    A. Dimitrios Colevas;Sue S. Yom;David G. Pfister;Sharon Spencer

  • American Society of Clinical Oncology Guideline on the Role of Bisphosphonates in Breast Cancer

    Bruce E. Hillner;James N. Ingle;James R. Berenson;Nora A. Janjan

  • Factors associated with complications in microvascular reconstruction of head and neck defects.

    Bhuvanesh Singh;Peter G. Cordeiro;Eric Santamaria;Ashok R. Shaha

  • American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants.

    Martee L. Hensley;Lynn M. Schuchter;Celeste Lindley;Neal J. Meropol

  • Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.

    Thomas Powles;Thomas Powles;Tibor Csőszi;Mustafa Özgüroğlu;Nobuaki Matsubara

Frequent Co-Authors

Nancy Y. Lee
Nancy Y. Lee Memorial Sloan Kettering Cancer Center
Jatin P. Shah
Jatin P. Shah Memorial Sloan Kettering Cancer Center
Dennis H. Kraus
Dennis H. Kraus Northwell Health
Michael J. Zelefsky
Michael J. Zelefsky Memorial Sloan Kettering Cancer Center
Axel Heidenreich
Axel Heidenreich University of Cologne
Ashok R. Shaha
Ashok R. Shaha Memorial Sloan Kettering Cancer Center
Suzanne L. Wolden
Suzanne L. Wolden Memorial Sloan Kettering Cancer Center
Richard J. Wong
Richard J. Wong Memorial Sloan Kettering Cancer Center
Louis B. Harrison
Louis B. Harrison Moffitt Cancer Center
Snehal G. Patel
Snehal G. Patel Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Aspiring medical professionals often explore diverse online degree options to advance their careers or change their specialization. One popular route is becoming a nurse, and there are multiple flexible paths available for both non-nurses and practicing RNs.

For those without a nursing background, direct entry msn programs for non-nursing majors online offer a fast-track into advanced nursing roles. Similarly, individuals looking for entry-level credentials can consider online adn programs for non nurses, providing a quicker entry point into the nursing profession.

Practicing RNs aiming to enhance their qualifications typically look for RN to BSN programs, but the average cost of rn to bsn programs is a key consideration when selecting the best option. For those seeking leadership or academic roles, an online phd in nursing delivers advanced expertise through flexible online study.

Whether advancing a current career or embarking on a new healthcare path, these online programs offer accessible and affordable ways to reach your goals in the field of medicine.

Best Scientists Citing David G. Pfister

Trending Scientists